Budd-Chiari Syndrome: Presentation, Management, and Prognosis

Area of Science:

• Hepatology
• Vascular Medicine
• Thrombosis Research

Background:

• Budd Chiari syndrome (BCS) is a rare hepatic vein obstruction causing liver congestion and dysfunction.
• It can manifest acutely, subacutely, or chronically, often affecting younger individuals.
• Risk factors include prothrombotic conditions, myeloproliferative disorders, oral contraceptive use, lower socioeconomic status, and malnutrition.

Purpose of the Study:

• To review current understanding of Budd Chiari syndrome (BCS) etiologies.
• To discuss diagnostic options, prognostic scores, and natural history, including pregnancy outcomes.
• To summarize treatment strategies and outcomes for BCS patients.

Main Methods:

• Literature review of Budd Chiari syndrome (BCS) research.
• Analysis of diagnostic criteria and prognostic scoring systems.
• Evaluation of treatment pathways including anticoagulation, shunting, and liver transplantation.

Main Results:

• BCS treatment follows a stepwise approach: anticoagulation, portosystemic shunting, and liver transplantation.
• Liver transplant outcomes for BCS, even with acute liver failure, are comparable to other indications.
• Pregnancy in BCS has favorable maternal but poor fetal outcomes; lifelong anticoagulation is common.

Conclusions:

• Budd Chiari syndrome (BCS) management requires a tailored, stepwise approach.
• Lifelong anticoagulation is frequently necessary for BCS patients, including transplant recipients.
• Further research is needed for chronic BCS, portal hypertension complications, and liver cancer.